Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Analyzing differences between patient and proxy on Patient Reported Outcomes in multiple sclerosis.
[The activation of the type I interferon signaling pathway in multiple sclerosis patients treated with russian analogue of Β-interferon-1b: transcriptome profiling data.]
The impact of the human genome project on complex disease.
A semi-automated measuring system of brain diffusion and perfusion magnetic resonance imaging abnormalities in patients with multiple sclerosis based on the integration of coregistration and tissue segmentation procedures.
Neural stem cell diversity and proteomics.
Delayed Central Nervous System Irradiation Effects in Rats - Part 2: Aggravation of Experimental Autoimmune Encephalomyelitis.
Astrocytic vesicle mobility in health and disease.
Comparison of Point Estimates and Average Thicknesses of Retinal Layers Measured Using Manual Optical Coherence Tomography Segmentation for Quantification of Retinal Neurodegeneration in Multiple Sclerosis.
Post trauma vision syndrome and visual midline shift syndrome.
Concurrent motor and cognitive function in multiple sclerosis: a motor overflow and motor stability study.
Therapeutic Potential of Cannabinoids in Neurodegenerative Disorders: A Selective Review.
Expression and regulation of human endogenous retrovirus W elements.
Consistency in Administration and Response for the Backward Push and Release Test: A Clinical Assessment of Postural Responses.
Impact of high intensity exercise on muscle morphology in EAE rats.
Cortical Pathology in RRMS: Taking a Cue from Four Sisters.
Transcranial direct current stimulation ameliorates tactile sensory deficit in multiple sclerosis.
Behavioural and molecular consequences of chronic cannabinoid treatment in Huntington's disease transgenic mice.
Differential Diagnosis of White Matter Lesions: Nonvascular Causes-Part II.
Gain of glycosylation: A new pathomechanism of myelin protein zero mutations.
Is it useful to perform carbon monoxide diffusion capacity and respiratory muscle function tests in patients with multiple sclerosis without disability?
[Neuromyelitis optica: a case report].
Comparison of Standard 1.5 T vs. 3 T Optimized Protocols in Patients Treated with Glatiramer Acetate. A Serial MRI Pilot Study.
Hemianopia and visual loss due to progressive multifocal leukoencephalopathy in natalizumab-treated multiple sclerosis.
Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice.
Smokers run increased risk of developing anti-natalizumab antibodies.

Pages